Edition:
United States

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

1.73USD
4:00pm EDT
Change (% chg)

$-0.05 (-2.82%)
Prev Close
$1.77
Open
$1.80
Day's High
$1.80
Day's Low
$1.73
Volume
7,193
Avg. Vol
53,668
52-wk High
$2.85
52-wk Low
$1.17

Chart for

About

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $110.27
Shares Outstanding(Mil.): 62.39
Dividend: --
Yield (%): --

Financials

  AFMD.OQ Industry Sector
P/E (TTM): -- 213.33 32.89
EPS (TTM): -0.76 -- --
ROI: -56.47 -3.69 13.14
ROE: -60.23 -5.73 15.15

BRIEF-Affimed Announces Proposed Public Offering Of Common Stock

* AFFIMED ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

Feb 12 2018

BRIEF-Affimed Reports New Data For AFM13 From Two Separate Clinical Trials

* AFFIMED REPORTS NEW DATA FOR AFM13 FROM TWO SEPARATE CLINICAL TRIALS IN HODGKIN AND CD30-POSITIVE LYMPHOMAS

Feb 01 2018

Earnings vs. Estimates